基于生物聚合物的纳米医学用于癌症治疗:机遇和挑战
Xixi Wu1, Yuan Xin1, Hengtong Zhang1
1NMPA Key Laboratory for Quality Research and Control of Tissue Regenerative Biomaterial, & Institute of Regulatory Science for Medical Device, & National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, 610064, People's Republic of China.
International journal of nanomedicine
|July 29, 2024
概括
生物聚合物正在成为针对癌症的纳米药物输送的有希望的材料,提供更好的药物疗效和减少对患者的伤害. 本综述详细介绍了它们的优点,局限性以及抗癌疗法的未来方向.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 癌症仍然是全球领先的健康挑战,常规治疗导致显著的副作用.
- 纳米技术为瘤部位提供有针对性的药物输送,最大限度地减少对健康组织的伤害.
- 生物聚合物具有独特的特性,使其适用于先进的纳米医药输送系统.
研究的目的:
- 审查纳米疗法和纳米医学策略在癌症治疗中的应用.
- 突出生物聚合物的特性,增强聚合物纳米药物交付.
- 综合总结当前关于蛋白质,多糖和基于脂质体的癌症纳米药物输送系统的研究.
主要方法:
- 关于基于生物聚合物的纳米医学最新研究的文献综述.
- 分析了五种蛋白质类别,九种多糖类,以及用于抗癌药物输送的脂质体.
- 评估生物聚合物的优势,局限性和临床应用的障碍.
主要成果:
- 在纳米药物输送中详细概述了白蛋白,凝,丝纤维素,,和费里丁.
- 契托桑,粉,氨酸,德克斯,纤维素,富可伊丹,卡拉基南,红素和百花素应用的全面概述.
- 讨论脂质体作为纳米药物输送系统的关键组成部分.
结论:
- 生物聚合物为开发有效和更安全的纳米抗癌药物输送系统提供了巨大的潜力.
- 了解生物聚合物特性对于优化纳米医药设计和应用至关重要.
- 需要进一步的研究来克服目前的局限性,并推进基于生物聚合物的纳米疗法.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K